Epidemiological and Genomic Insights into Linezolid-Non-Susceptible Enterococci in Pediatric Patients

Chao Fang1, Zheng Zhou1, Xiucai Zhang1

  • 1Department of Clinical Laboratory, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents' Health and Diseases, No. 3333 Binsheng road, Hangzhou, Zhejiang Province, China.

Current Microbiology
|February 5, 2026
PubMed

Insights

Linezolid-non-susceptible enterococci (LNSE) are a growing threat in pediatric healthcare. This study reveals key genetic traits of LNSE in children, providing crucial data for infection control strategies.

Area of Science:

  • Microbiology
  • Genomics
  • Infectious Diseases

Background:

  • Enterococci are significant causes of healthcare-associated infections in children.
  • Linezolid-non-susceptible enterococci (LNSE) pose a growing challenge to treating multidrug-resistant Gram-positive infections.
  • Limited epidemiological and genomic data exist for pediatric LNSE.

Purpose of the Study:

  • To investigate the epidemiology and genomics of linezolid-non-susceptible enterococci (LNSE) in a pediatric population.
  • To identify resistance mechanisms and virulence factors in pediatric LNSE strains.
  • To inform targeted prevention and control strategies for LNSE in children.

Main Methods:

  • Analysis of 26 LNSE strains isolated from pediatric patients.
  • Identification and characterization using MALDI-TOF MS, Vitek2 Compact, and micro-broth dilution.
  • Molecular techniques including MLST, resistance/virulence gene detection, and pan-genome analysis.

Main Results:

  • Enterococcus faecalis (88.5%) was the dominant species, with ST16 being the most prevalent sequence type.
  • All analyzed strains carried the optrA and fexA genes, conferring resistance to linezolid.
  • Pan-genome analysis of E. faecalis indicated an open genome with evidence of horizontal gene transfer.

Conclusions:

  • This study provides essential epidemiological and genomic insights into pediatric LNSE.
  • The findings highlight the genetic basis of linezolid resistance in pediatric enterococci.
  • Data generated will aid in developing effective strategies to combat LNSE infections in children.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
314
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
237
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
305
Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
40.8K
Introduction to Epidemiology01:26

Introduction to Epidemiology

Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
1.9K